METACARE CO., Ltd. (KRX:118000)
South Korea · Delayed Price · Currency is KRW 871.00
-64.00 (-6.84%)
Nov 4, 2026, 3:30 PM KST
METACARE CO. Market Cap
METACARE CO. has a market cap or net worth of 19.21 billion as of November 4, 2026. It is the 39,209th most valuable company in the world and the 2,439th biggest in South Korea. Its market cap has decreased by 64.39% in one year.
Market Cap
19.21B
Enterprise Value
94.19B
Revenue
39.95B
Global Rank
Country Rank
#2,439 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since January 4, 2010, METACARE CO.'s market cap has decreased from 39.82B to 19.21B, a decrease of -51.77%. That is a compound annual growth rate of -4.24%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 4, 2026 | 19.21B | -63.34% |
| Dec 30, 2025 | 52.39B | 12.75% |
| Dec 30, 2024 | 46.47B | -18.64% |
| Dec 28, 2023 | 57.11B | 29.66% |
| Dec 29, 2022 | 44.05B | -64.01% |
| Dec 30, 2021 | 122.39B | -14.64% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 65.75T |
| Celltrion | 43.95T |
| ALTEOGEN | 14.83T |
| Samsung Epis Holdings | 7.79T |
| BCWORLD PHARM. | 28.67B |
| LabGenomics | 28.24B |
| Tdspharm | 24.77B |
| Aprogen Biologics | 21.77B |